Bruker announced on April 11, 2025, a significant menu expansion of its validated PCR assays on the BeGenius® sample-to-answer molecular diagnostics system at the ESCMID Global conference. This enhances its offerings in infectious disease testing.
The ELITe BeGenius system is an automated PCR platform providing a broad range of molecular in-vitro diagnostics tests across multiple clinical areas, including transplant pathogen monitoring and healthcare-associated infections. It can run up to 72 tests during an 8-hour shift and handles diverse human sample types.
Additionally, Bruker introduced the new IR Tracker™ software for the IR Biotyper frontline solution, which accelerates the detection of suspected outbreak isolates and provides color-coded reports on microbial strain relatedness. This aims to facilitate fast and cost-effective detection or rule-out of potential hospital outbreaks.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.